Status: Recruiting
OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases
The purpose of this trial is to identify a safe maximum tolerated dose level for MRI-guided Stereotactic Body Radiation Therapy (SBRT) treatment of bowel and liver metastases, respectively. Eligible participants will be on study for up to 12 months.
Participants needed: 32
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of Wisconsin, MadisonUpdated: Jun 11, 2026Locations: 1
Eligibility criteria
Have a diagnosis of histologically confirmed or clinically suspected metastatic... [+24]
Is currently participating and receiving study therapy or has participated in a... [+12]